The expressions of ATF6, CHOP, XBP1, EMC6, and APAF1 are significantly involved in PC progression, and ATF6 overexpression and the inhibition of EMC6 or APAF1 expression are associated with poor clinical outcome in PC patients. Here, ATF6 is linked to pachyonychia congenita.